A high-fidelity RNA-targeting Cas13 restores paternal Ube3a expression and improves motor functions in Angelman syndrome mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A high-fidelity RNA-targeting Cas13 restores paternal Ube3a expression and improves motor functions in Angelman syndrome mice

Published:2023-07 Issue:7 Volume:31 Page:2286-2295
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Li Jinhui,Shen Zhixin,Liu Yajing,Yan Zixiang,Liu Yuanhua,Lin Xiang,Tang Junjie,Lv Ruimin,Geng Guannan,Xiong Zhi-Qi,Zhou Changyang,Yang Hui

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference40 articles.

1. Angelman syndrome - insights into a rare neurogenetic disorder;Buiting;Nat. Rev. Neurol.,2016

2. Expression of the Rho-GEF Pbl/ECT2 is regulated by the UBE3A E3 ubiquitin ligase;Reiter;Hum. Mol. Genet.,2006

3. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18;Huibregtse;EMBO J.,1991

4. UBE3A/E6-AP regulates cell proliferation by promoting proteasomal degradation of p27;Mishra;Neurobiol. Dis.,2009

5. The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc;Greer;Cell,2010

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A CRISPR/RfxCas13d-mediated strategy for efficient RNA knockdown in mouse embryonic development;Science China Life Sciences;2024-08-02

2. Ube3a unsilencer for the potential treatment of Angelman syndrome;Nature Communications;2024-07-08

3. Programmable RNA targeting with CRISPR-Cas13;RNA Biology;2024-05-19

4. Targeted PLK1 suppression through RNA interference mediated by high‐fidelity Cas13d mitigates osteosarcoma progression via TGF‐β/Smad3 signalling;Journal of Cellular and Molecular Medicine;2024-05

5. Engineered RNA‐Binding Proteins: Studying and Controlling RNA Regulation;Israel Journal of Chemistry;2024-02-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3